An Austrian cross-sectional study showed that higher values of dimethylarginine, von Willebrand factor, homocysteine, and β-2-glycoprotein antibodies, and lower levels of homoarginine and tryptophan in post-COVID-19 patients were associated with microangiopathy development (p < 0.05). The gene discussed is VWF; the disease is COVID-19.